Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
Article
New histopathologic marker may aid dermatomyositis diagnosis
The detection of sarcoplasmic myxovirus resistance A expression in immunohistochemical analysis of muscle biopsy in patients suspected of having...
Article
When primary anti-TNF fails in axial spondyloarthritis, consider comorbidities or second anti-TNF
A second TNFi may be useful in axSpA patients with primary inefficacy to their first TNFi, but also consider the impact of painful comorbidities...
Article
Medicare payments set for infliximab biosimilar Inflectra
Medicare will now cover payment for the infliximab biosimilar drug Inflectra.
Article
MACRA’s near and potential long-term future outlined for rheumatology
WASHINGTON - Now that implementation of the Medicare Access and CHIP Reauthorization Act is on rheumatologists' doorsteps, figuring out what is...
Article
Lack of natalizumab concentration increase before PML argues against extending dosing interval
Serum concentrations of natalizumab do not appear to rise before patients with relapsing-remitting multiple sclerosis are diagnosed with...
Article
Fiber may play role in lessening knee pain, OA development
Consumption of dietary fiber at the recommended average intake of 25 g per day was associated with lower risks of developing symptomatic knee...
Article
Infliximab biosimilar posts mostly reassuring data in Norway’s NOR-SWITCH study
WASHINGTON – Data from the first randomized trial of switching from an originator biologic to a biosimilar of the originator indicate that the...
Article
Rheumatology malpractice litigation investigated for first time
WASHINGTON
Article
OA progresses equally with new focal partial- or full-thickness cartilage damage
A small, partial-thickness focal cartilage defect in the tibiofemoral joint compartment has the same impact on osteoarthritis disease progression...
Article
Shared medical appointment model shows potential for fibromyalgia patients
Fibromyalgia patients who participated in shared medical appointments staffed by an interdisciplinary team at a rural academic medical center...
Article
RA prevention trials seek to stop clinical onset of disease
Investigators across the United States and Europe hope to answer questions surrounding the feasibility of preventing rheumatoid arthritis in a...
News
Pain starting in knee later arises in other joints
Key clinical point:People with frequently painful knees often develop pain in joints outside the knee, and the sites vary from person to person....
News
Biosimilar version of etanercept gains FDA approval
A biosimilar of etanercept received clearance for marketing from the FDA for all of the inflammatory disease indications held by the reference...
